Jim O’Mara is the founder of Neurogastrx. Neurogastrx has raised $105M in total funding. Latest round: Series B. Based in Woburn, Massachusetts.
Jim O'Mara is the President and CEO of Neurogastrx, a biopharmaceutical company focused on therapies for gastrointestinal disorders. He was appointed CEO in January 2018 when the company raised its Series A funding. Under his leadership, Neurogastrx has secured significant funding rounds to advance its drug pipeline.
Full founder directory · Investor directory · Company funding database · Fundraising library